Pharmexcil Web
googleplus youtube Facebook Twitter


Product Categories

Home» Circulars» Technical Sessions During 27th 28th April 2017 5th Edition Of Iphex 2017 At Hitex Hyderabad Back
Technical Sessions during 27th -28th April, 2017, 5th Edition of iPHEX 2017 at HITEX, Hyderabad



Ref: PXL/H.O./CIR-002/2017-18                                                                      Date: 11.04.2017


Meet FDA Officials of over 20 Countries at
iPHEX 2017
27-29 April 2017

Technical Sessions on 27th & 28th April 2017

5th Edition of iPHEX 2017 at HITEX, Hyderabad

International Regulations-An Overview and Challenges (Session I)

International Procurement Practices in Pharmaceuticals & Vaccines (Session II)

Strategies to develop APIs & KSMs indigenously (Session III)

All the Members of Council,

Dear Sir / Madam


Subject: Technical Sessions during 27th -28th April, 2017, 5th Edition of iPhex 2017 at HITEX, Hyderabad.


We are pleased to inform that Pharmexcil in line with Brand India Pharma Campaign (BIPC), initiated by Ministry of Commerce and Industry, Govt. of India, is organizing the fifth edition of IPHEX (International Expo for Pharma and Healthcare) in Hyderabad during 27th-29th April 2017.


Over 580 Overseas Delegates, including about 50 drug regulators from more 100 countries are expected to participate in this event. About 300 exporters including several big pharma companies from India are taking part in this important exhibition. This exhibition is designed to offer excellent opportunities to explore business collaboration, technology transfer and investment opportunities. A number of seminars, interactions and one-to-one meets with importers and regulators are being organized during the period of event.


On the sidelines of this flagship event, Pharmexcil is organizing technical sessions during 27-28th April 2017 covering the following important topics:





Session I

27th April 2017

International Regulations-An Overview and Challenges

Session II

28th April 2017

International Procurement Practices in Pharmaceuticals

Session III

28th April 2017

Strategies to reduce import dependence of APIs, KSMs and Intermediates

Technical sessions will have deliberations followed by Panel discussions.



  • Regulatory Officials from Brazil, Afghanistan, Azerbaijan, Benin, Burundi, Côte d'Ivoire, Congo, Cambodia, Ethiopia, Ghana, Liberia, Mali, Nigeria, Nepal, Sri Lanka, Syria, Senegal, Togo, Tunisia, and Uganda have confirmed their participation.
  • Presentations on Drug regulatory updates and Registration procedures
  • Audit preparedness and facing audits.
  • Deliberations on International Health and Procurement practices by WHO, UNICEF, Bill & Melinda Gates Foundation, Aga Khan Foundation, Tamil Nadu Medical Services Corporation (TNMSC)
  • Eminent Scientists from Premier Research institutes like IICT, NCL, ICT and Institute of Life Sciences and technocrats from manufacturing side participating to deliberate and devise strategies for indigenous development of APIs, KSMs and Intermediates.  

Venue: HITEX, Hyderabad

Date : 27th & 28th April, 2017                       

Time: 10.00 am to 1.00 pm / 2.00 pm to 5.00 pm

Registration: No Registration fee.


Members are requested to take advantage of this opportunity and register your participation by sending email to  


For more information, please write to


With regards,

Udaya Bhaskar

Director General

H.O.: 101, Aditya Trade Centre, Ameerpet, Hyderbad-500038
Tel: +91-40-23735462/66, Fax: +91-40-23735464
Email: Website:

Disclaimer: The translation into various languages is provided for the benefit of visitors.  Pharmexcil is not responsible for any wrong interpretations/mistakes.
For authenticated information in this site, please contact
Site visited Free Web Counters
  (From: 21-06-2012)
Copyright © 2009 Pharmexcil. All rights reserved.
Powered by: iBongo Inc